Koy, Anne, Kuehn, Andrea A., Huebl, Julius, Schneider, Gerd-Helge, van Riesen, Anne K., Eckenweiler, Matthias, Rensing-Zimmermann, Cornelia, Coenen, Volker Arnd, Krauss, Joachim K., Saryyeva, Assel, Hartmann, Hans, Haeussler, Martin, Volkmann, Jens, Matthies, Cordula, Horn, Annette, Schnitzler, Alfons ORCID: 0000-0002-6414-7939, Vesper, Jan, Gharabaghi, Alireza, Weiss, Daniel, Bevot, Andrea, Marks, Warren, Pomykal, Angela, Monbaliu, Elegast, Borck, Guntram, Mueller, Joerg, Prinz-Langenohl, Reinhild, Dembek, Till, Visser-Vandewalle, Veerle, Wirths, Jochen, Schiller, Petra, Hellmich, Martin and Timmermann, Lars . Quality of Life after Deep Brain Stimulation of Pediatric Patients With Dyskinetic Cerebral Palsy: A Prospective, Single-Arm, Multicenter Study With a Subsequent Randomized Double-Blind Crossover (STIM-CP). Mov. Disord.. HOBOKEN: WILEY. ISSN 1531-8257

Full text not available from this repository.

Abstract

Background Patients with dyskinetic cerebral palsy are often severely impaired with limited treatment options. The effects of deep brain stimulation (DBS) are less pronounced than those in inherited dystonia but can be associated with favorable quality of life outcomes even in patients without changes in dystonia severity. Objective The aim is to assess DBS effects in pediatric patients with pharmacorefractory dyskinetic cerebral palsy with focus on quality of life. Methods The method used is a prospective, single-arm, multicenter study. The primary endpoint is improvement in quality of life (CPCHILD [Caregiver Priorities & Child Health Index of Life with Disabilities]) from baseline to 12 months under therapeutic stimulation. The main key secondary outcomes are changes in Burke-Fahn-Marsden Dystonia Rating Scale, Dyskinesia Impairment Scale, Gross Motor Function Measure-66, Canadian Occupational Performance Measure (COPM), and Short-Form (SF)-36. After 12 months, patients were randomly assigned to a blinded crossover to receive active or sham stimulation for 24 hours each. Severity of dystonia and chorea were blindly rated. Safety was assessed throughout. The trial was registered at ClinicalTrials.gov, number NCT02097693. Results Sixteen patients (age: 13.4 +/- 2.9 years) were recruited by seven clinical sites. Primary outcome at 12-month follow-up is as follows: mean CPCHILD increased by 4.2 +/- 10.4 points (95% CI [confidence interval] -1.3 to 9.7; P = 0.125); among secondary outcomes: improvement in COPM performance measure of 1.1 +/- 1.5 points (95% CI 0.2 to 1.9; P = 0.02) and in the SF-36 physical health component by 5.1 +/- 6.2 points (95% CI 0.7 to 9.6; P = 0.028). Otherwise, there are no significant changes. Conclusion Evidence to recommend DBS as routine treatment to improve quality of life in pediatric patients with dyskinetic cerebral palsy is not yet sufficient. Extended follow-up in larger cohorts will determine the impact of DBS further to guide treatment decisions in these often severely disabled patients.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Koy, AnneUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kuehn, Andrea A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Huebl, JuliusUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schneider, Gerd-HelgeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
van Riesen, Anne K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Eckenweiler, MatthiasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rensing-Zimmermann, CorneliaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Coenen, Volker ArndUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Krauss, Joachim K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Saryyeva, AsselUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hartmann, HansUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Haeussler, MartinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Volkmann, JensUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Matthies, CordulaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Horn, AnnetteUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schnitzler, AlfonsUNSPECIFIEDorcid.org/0000-0002-6414-7939UNSPECIFIED
Vesper, JanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gharabaghi, AlirezaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Weiss, DanielUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bevot, AndreaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Marks, WarrenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pomykal, AngelaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Monbaliu, ElegastUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Borck, GuntramUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mueller, JoergUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Prinz-Langenohl, ReinhildUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dembek, TillUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Visser-Vandewalle, VeerleUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wirths, JochenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schiller, PetraUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hellmich, MartinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Timmermann, LarsUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-604562
DOI: 10.1002/mds.28898
Journal or Publication Title: Mov. Disord.
Publisher: WILEY
Place of Publication: HOBOKEN
ISSN: 1531-8257
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
RATING-SCALE; DYSTONIA; CHILDREN; MANAGEMENT; OUTCOMES; IMPACTMultiple languages
Clinical NeurologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/60456

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item